Clinical

Codiak Launch is Big News

exosome rna

Codiak Is Launched To Exploit The Exosome | Chemical … cen.acs.org/…/Codiak–Launched-Exploit-… Chemical & Engineering News 6 days ago – Looking to exploit a natural cellular communication highway, a new company, Codiak BioSciences, has launched with $80 million in venture … Codiak ...

Read More »

Exosomes – integral component to the dynamic and reciprocal cross-talk between tumour cells and the metastatic niche

exosome rna

The development of life-threatening cancer metastases at distant organs requires disseminated tumour cells’ adaptation to, and co-evolution with, the drastically different microenvironments of metastatic sites. Cancer cells of common origin manifest distinct gene expression patterns after metastasizing to different organs. ...

Read More »

Investors Watch List – Capricor Therapeutics, Inc.

exosome rna

Capricor Therapeutics, Inc. (NASDAQ:CAPR) belongs to Healthcare sector. Its weekly performance is -2.50%. On last trading day company shares ended up $4.68. Capricor Therapeutics, Inc. (NASDAQ:CAPR) distance from 50-day simple moving average (SMA50) is -22.39%. On 17 June, Capricor Therapeutics, ...

Read More »